Delivery Order SPE2DB22D3102-SPE2DB25FL2MD
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Triamterene-HCTZ 37.5-25 mg tablets in a quantity of 500 units, with a ceiling value of $1,267.99. This is a firm fixed-price delivery order with an ultimate completion date of August 8, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,085.19 to AmerisourceBergen Drug Corp for 500 tablets of Triamterene-HCTZ 37.5-25 mg, a generic combination diuretic medication commonly used in the treatment of hypertension. Awarded on July 25, 2025, with an ultimate completion date of July 28, 2025, this firm fixed price delivery order represents a routine pharmaceutical procurement under a non-set-aside competitive award. The contract will be performed at...
- The Defense Logistics Agency awarded a $66,680 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 500 tablets of the pharmaceutical combination product Triamterene-HCTZ 37.5-25 mg. Amerisourcebergen will deliver the medication from its facility in Conshohocken, Pennsylvania to the DLA by August 24, 2023 under the terms of the order. As a major distributor of pharmaceuticals and medical supplies, Amerisourcebergen regularly supports DLA's procurement and provisioning...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,235.12 firm fixed price contract is for the delivery of Triamterene-HCTZ 37.5-25 mg tablets in 500-count bottles. The award has no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- The Defense Logistics Agency awarded a $575.70 delivery order to Amerisourcebergen Drug Corp Corporate Office Division for the supply of 100 tablets of triamterene-hclz, 75-50 mg. The order was placed under an indefinite-delivery/indefinite-quantity contract vehicle to support the Department of Defense's pharmaceutical needs. Performance will take place in Conshohocken, Pennsylvania over a one-day period from July 24-25, 2023. The firm fixed price order was awarded competitively with no...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $447.99 to Amerisourcebergen Drug Corp for the supply of 500 tablets of the pharmaceutical product TRIAMTERENE-HCTZ 37.5-25 MG. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is September 12-13, 2023. Amerisourcebergen Drug Corp is a division of Amerisourcebergen Corporation, which will serve as the prime contractor without the use of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,668.35 firm fixed-price delivery order is for the supply of TRIAMTERENE-HCTZ 37.5-25 MG TB 500S, a cardiovascular medication. The contract has an ultimate completion date of December 3, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $1,003.27, is a delivery order with a firm fixed price pricing type. It is for the supply of TRIAMTERENE-HCTZ 37.5-25 MG TB 500S, a generic pharmaceutical product, with a completion date of June 10, 2024. The contract does not have a set-aside designation, indicating open competition....
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $3,000 to Amerisourcebergen Drug Corporation for the supply of 500 tablets of triamterene-hctz 37.5-25 mg. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the requested pharmaceutical products from its facility in Conshohocken, Pennsylvania to fulfill the agency's requirements. The single delivery is to be completed within a one day period in September 2023. Amerisourcebergen...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $41,580 to Amerisourcebergen Drug Corporation to supply 100 tablets of the prescription medication triamterene-hctz 37.5-25 mg. Performance will take place in Conshohocken, Pennsylvania under Amerisourcebergen Corporation's corporate office division contract vehicle. No set aside designation or subcontractors were indicated. This order supports the Defense Logistics Agency's mission to provide pharmaceuticals and...
- SPE2DB22D3102Indefinite Delivery Contract
- SPE2DB22D3102-SPE2DB25FL2MDDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,730.63 to AmerisourceBergen Drug Corp for the supply of Triamterene-HCTZ 37.5-25 mg tablets in quantities of 500 units. This non-set-aside, firm fixed-price delivery order was competitively awarded on August 8, 2025, with an ultimate completion date of August 11, 2025. The medication will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary operations. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies a comprehensive portfolio of generic and brand-name medications, vaccines, and medical supplies to support military and veteran healthcare systems worldwide. The underlying IDC serves as a flexible procurement vehicle enabling the company to fulfill diverse pharmaceutical requirements across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 8/8/25 |